Too few prostate cancer patients receiving active surveillance
(HealthDay)—A majority of U.S. men with low-risk prostate cancer who are eligible for active surveillance still undergo treatment, according to a new report published online June 29 in JAMA Internal Medicine.
Jul 1, 2015
0
8